» Articles » PMID: 35087503

The Activated Macrophage - A Tough Fortress for Virus Invasion: How Viruses Strike Back

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Jan 28
PMID 35087503
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages (Mφ) are innate immune cells with a variety of functional phenotypes depending on the cytokine microenvironment they reside in. Mφ exhibit distinct activation patterns that are found within a wide array of activation states ranging from the originally discovered classical pro-inflammatory (M1) to the anti-inflammatory (M2) with their multi-facades. M1 cells are induced by IFNγ + LPS, while M2 are further subdivided into M2a (IL-4), M2b (Immune Complex) and M2c (IL-10) based on their inducing stimuli. Not surprisingly, Mφ activation influences the outcome of viral infections as they produce cytokines that in turn activate cells of the adaptive immune system. Generally, activated M1 cells tend to restrict viral replication, however, influenza and HIV exploit inflammation to support their replication. Moreover, M2a polarization inhibits HIV replication at the post-integration level, while HCMV encoded hrIL-10 suppresses inflammatory reactions by facilitating M2c formation. Additionally, viruses such as LCMV and Lassa Virus directly suppress Mφ activation leading to viral chronicity. Here we review how Mφ activation affects viral infection and the strategies by which viruses manipulate Mφ polarization to benefit their own fitness. An understanding of these mechanisms is important for the development of novel immunotherapies that can sway Mφ phenotype to inhibit viral replication.

Citing Articles

The Generation of Genetically Engineered Human Induced Pluripotent Stem Cells Overexpressing IFN-β for Future Experimental and Clinically Oriented Studies.

Sheveleva O, Protasova E, Grigoreva E, Butorina N, Kuziaeva V, Antonov D Int J Mol Sci. 2024; 25(22).

PMID: 39596521 PMC: 11595023. DOI: 10.3390/ijms252212456.


Classical swine fever: Unveiling the complexity through a multifaceted approach.

Khairullah A, Effendi M, Moses I, Fauzia K, Puspitasari Y, Riwu K Open Vet J. 2024; 14(10):2497-2508.

PMID: 39545196 PMC: 11560257. DOI: 10.5455/OVJ.2024.v14.i10.1.


HSV1-induced enhancement of productive HIV-1 replication is associated with interferon pathway downregulation in human macrophages.

Andrade V, Pereira-Dutra F, Abrantes J, Miranda M, Souza T Mem Inst Oswaldo Cruz. 2024; 119:e240102.

PMID: 39476027 PMC: 11520659. DOI: 10.1590/0074-02760240102.


Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy.

Lecoultre M, Walker P, El Helali A Clin Exp Med. 2024; 24(1):202.

PMID: 39196415 PMC: 11358230. DOI: 10.1007/s10238-024-01443-8.


Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids.

Patel M, Tiwari S, Wang Y, ONeill S, Wu J, Omo-Lamai S bioRxiv. 2024; .

PMID: 38915627 PMC: 11195186. DOI: 10.1101/2024.06.11.598533.


References
1.
Nathan C, Hibbs Jr J . Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991; 3(1):65-70. DOI: 10.1016/0952-7915(91)90079-g. View

2.
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M . The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25(12):677-86. DOI: 10.1016/j.it.2004.09.015. View

3.
Gomez-Villamandos J, Bautista M, Sanchez-Cordon P, Carrasco L . Pathology of African swine fever: the role of monocyte-macrophage. Virus Res. 2013; 173(1):140-9. DOI: 10.1016/j.virusres.2013.01.017. View

4.
Keppler S, Rosenits K, Koegl T, Vucikuja S, Aichele P . Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS One. 2012; 7(7):e40865. PMC: 3398954. DOI: 10.1371/journal.pone.0040865. View

5.
Boumaza A, Gay L, Mezouar S, Bestion E, Diallo A, Michel M . Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis. J Infect Dis. 2021; 224(3):395-406. PMC: 7928817. DOI: 10.1093/infdis/jiab044. View